Interestingly, administration of a commonly prescribed diabetes drug, pioglitazone, which is also a PPAR-γ agonist, was associated with reduced dementia risk in patients who had non-insulin-dependent diabetes mellitus [158]. Here, PPARG is linked to diabetes mellitus.